Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules
Source abstract
Abstract
With the goal of achieving constant release of large biological molecules over an extended period of time we focused on hybrid inorganic/organic nanoparticles. We synthesized poly(ethylene glycol) (PEG)-coated mesoporous silica nanoparticles (MSNs) with incorporated trypsin inhibitor (TI), a model protein molecule for growth factors. Due to the goal of incorporating large protein molecules the pore size of the as-synthesized MSNs was expanded by a hydrothermal treatment prior to TI incorporation. In vitro release from the MSNs without the thin polymer film shows an initial burst followed by continuous release. In the case of polymer-coated MSNs the initial burst release was completely suppressed and approximate zero order release was achieved for 4 weeks.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Glycosylation and Glycoproteins Research · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Strategies in the design of nanoparticles for therapeutic applications10.1038/nrd2591 ↗
2. Biocompatible controlled release polymers for delivery of polypeptides and growth factors10.1002/jcb.240450406 ↗
3. Incorporation and release of fluoresce in isothiocyanate-linked dextrans from a bead-formed macroporous hydrophilic matrix with potential for sustained release10.1016/0142-9612(93)90016-U ↗
4. Novel preparation of poly(vinyl alcohol) microparticles without crosslinking agent for controlled drug delivery of proteins10.1016/0168-3659(93)90156-Y ↗
5. Physicochemical characterization of polymeric injectable implant delivery system10.1016/0168-3659(94)00097-E ↗
6. Recent studies and molecular analysis of drug release from swelling-controlled devices
7. Water-soluble dendritic-linear triblock copolymer-modified magnetic nanoparticles: preparation, characterization and drug release properties10.1039/c1jm11613d ↗
8. Hyperbranched polymer-drug conjugates with high drug payload for enhanced cellular delivery10.1007/s11095-004-7670-x ↗
9. MPEG-PLA microspheres with narrow size distribution increase the controlled release effect of recombinant human growth hormone10.1039/c1jm12643a ↗
10. Double-walled microspheres for drug delivery10.1557/PROC-331-97 ↗
11. Bioceramics: materials characteristics vs in vivo behavior
12. Bioactive material template for in vitro synthesis of bone tissue10.1002/jbm.820290311 ↗
13. Fabrication, characterization and evaluation of bioceramic hollow microspheres used as microcarriers for 3-D bone tissue formation in rotating bioreactors10.1016/S0142-9612(98)00183-5 ↗
14. Bone graft and bone graft substitutes: a review of current technology and applications10.1002/jab.770020307 ↗
15. In vitro release kinetics of biologically active transforming growth factorβ 1 from a novel xero-gel carrier10.1016/S0142-9612(97)00008-2 ↗
16. Newest factors in fracture healing10.1097/00003086-199204000-00036 ↗
17. Investigation of a hydroxyapatite and calcium sulfate composite supplemented with an osteo inductive factor10.1002/jbm.820240602 ↗
18. Chondroosteogenetic response to crude bone matrix proteins bound to hydroxyapatite10.1097/00003086-198704000-00030 ↗
19. Calcium phosphate ceramic coatings as carriers of vancomycin10.1016/S0142-9612(96)00190-1 ↗
20. Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris10.1097/00003086-198809000-00043 ↗
21. Sol–gel carrier systems for controlled drug delivery10.1023/A:1008603622543 ↗
22. Sol–gel derived carrier for the controlled release of proteins10.1016/S0142-9612(99)00066-6 ↗
23. In vitro behavior of silica-based xerogels intended as controlled release carriers10.1111/j.1151-2916.1999.tb01861.x ↗
24. Effect of synthesis parameters of the sol–gel-processed spray-dried silica gel microparticles on the release rate of dexmedetomidine10.1016/S0142-9612(02)00016-9 ↗
25. In vivo tissue response to resorbable silica xerogels as controlled-release materials10.1016/j.biomaterials.2004.04.004 ↗
26. Nanostructural control of implantable xerogels for the controlled release of biomolecules
27. Revisiting silica based ordered mesoporous materials: medical applications10.1039/B509744D ↗
28. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization10.1002/jor.20348 ↗
29. Emulsified sol–gel silica microspheres for controlled drug delivery10.1016/j.biomaterials.2008.09.066 ↗
30. Recent progress in the synthesis and applications of MCM-41 based mesoporous materials – a short review10.1080/17458080600812757 ↗
31. Effect of surfactant concentration on the morphology and texture of MCM-41 materials10.1021/jp800898n ↗
32. Beck JS, Chu CTW, Johnson ID, Kresge CT, Leonowicz ME, Roth WJ, et al. Synthetic porous crystalline material its synthesis and use. WO Patent No. 91-11 390, 1991.
33. Influence of pore size of MCM-41 matrices on drug delivery rate10.1016/j.micromeso.2003.12.012 ↗
34. Morphological control of room-temperature ionic liquid templated mesoporous silica nanoparticles for controlled release of antibacterial agents10.1021/nl048774r ↗
35. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials10.1021/ja062286z ↗
36. Supramolecular nano valves controlled by proton abstraction and competitive binding10.1021/cm061682d ↗
37. Construction of a pH-driven supramolecular nanovalve10.1021/ol0612509 ↗
38. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules10.1021/ja028650l ↗
39. A reversible molecular valve10.1002/adma.200305165 ↗
40. An operational supramolecular nanovalve10.1021/ja039424u ↗
41. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica10.1038/nature01362 ↗
42. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking10.1096/fj.05-4288fje ↗
43. Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death10.2217/17435889.3.4.507 ↗
44. Protein assay sensitive at nanogramlevels10.1016/0003-2697(87)90051-0 ↗
45. Small angle neutron scattering study of the structure and formation of ordered mesoporesin silica10.1557/PROC-371-47 ↗
46. 1982
47. Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices10.1002/jps.2600521210 ↗